2m 2m 2m 2m 2m 2m 2m
TREACE MED CNCPT (TMCI)
NASDAQ
$4.27+$0.13 (+3.14%)
Price as of Oct 22, 2026 7:30 PM EDT- $269.2MMarket Cap
- -39.65%1-Year Change
- Medical DevicesIndustry
TREACE MED CNCPT (TMCI)
$4.27+$0.13 (+3.14%)
TMCI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.14 | ||
Change | +$0.07 (+1.72%) | ||
Open | $4.05 | ||
High | $4.14 | ||
Low | $3.85 | ||
Previous Close | $4.07 | ||
Volume | 196,643 | ||
30-Day Average Volume | 220,859 | ||
1-Week Change | 2.48% | ||
1-Month Change | -7.59% | ||
1-Year Change | -39.65% | ||
3-Year Change | -58.22% | ||
5-Year Change | -79.25% | ||
Fundamentals | |||
Shares Outstanding | 65.0M | ||
Total Assets | $181.1M | ||
Market Cap | $269.2M | ||
Enterprise Value | $315.8M | ||
Period: QTR TTM FY | |||
Revenue | $45.4M | ||
Net Income | -$15.9M | ||
Free Cash Flow | -$6.9M | ||
EBIT | -$14.3M | ||
EBITDA | -$12.4M | ||
Net Working Capital | $79.0M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 4 | ||
P/E | -17 | ||
PEG | -1 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -57 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue